MEK inhibitors against MET-amplified non-small cell lung cancer
about
Driver genes in non-small cell lung cancer: Characteristics, detection methods, and targeted therapies.Hepatocyte growth factor produced in lung fibroblasts enhances non-small cell lung cancer cell survival and tumor progression.Novel 3D Liquid Cell Culture Method for Anchorage-independent Cell Growth, Cell Imaging and Automated Drug Screening.[Progress of c-MET Signaling Pathway and TKIs in Non-small Cell Lung Cancer].The expression of HOXA13 in lung adenocarcinoma and its clinical significance: A study based on The Cancer Genome Atlas, Oncomine and reverse transcription-quantitative polymerase chain reaction.
P2860
MEK inhibitors against MET-amplified non-small cell lung cancer
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 17 October 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
MEK inhibitors against MET-amplified non-small cell lung cancer
@en
MEK inhibitors against MET-amplified non-small cell lung cancer.
@nl
type
label
MEK inhibitors against MET-amplified non-small cell lung cancer
@en
MEK inhibitors against MET-amplified non-small cell lung cancer.
@nl
prefLabel
MEK inhibitors against MET-amplified non-small cell lung cancer
@en
MEK inhibitors against MET-amplified non-small cell lung cancer.
@nl
P2093
P2860
P356
P1476
MEK inhibitors against MET-amplified non-small cell lung cancer
@en
P2093
Hidetoshi Hayashi
Hiroshi Mizuuchi
Kazuko Sakai
Kazuto Nishio
Masato Chiba
Masato Terashima
Shuta Tomida
Tetsuya Mitsudomi
Yoshihiko Fujita
P2860
P304
P356
10.3892/IJO.2016.3736
P577
2016-10-17T00:00:00Z